TTAM Research Institute to acquire 23andMe in a $305m deal.

TTAM Research Institute, a nonprofit organization, agreed to acquire 23andMe, a personal genomics and biotechnology company, in a $305m deal. “We are pleased that the competitive bidding process has resulted in significantly more value to our stakeholders while enhancing critical protections around customer privacy, choice and consent with respect to their genetic data. As 23andMe’s founder, Ms. Wojcicki is well positioned to advance the Company’s founding vision of helping people access, understand and gain health benefits through greater understanding of the human genome. We will work to complete the transaction quickly so that 23andMe can begin its next chapter as a nonprofit,” Mark Jensen, 23andMe Chair of the Board and member of the Special Committee of the Board of Directors.